Tag: Epicutaneous Immunotherapy (EPIT)

Test Tubes

Adult Peanut Allergy: Therapy Cleared to Begin Phase IIa Trials

Antibody targets trigger also implicated in other food allergies, atopic diseases, and asthma.
Packaged Foods

Study: Peanut Immunotherapy Significantly Reduces Risks Due to Cross-Contact in Common...

The study model used common packaged foods such as cookies, ice cream, and doughnuts as references.

Viaskin Patch Delivers Long-Lasting Peanut Desensitization After Phase IIb Trial

The study was designed to assess the long-term efficacy and safety of the treatment in subjects that had graduated from their earlier VIPES trial.
DBV Patch Closeup

Study: EPIT (Skin Patch) Therapy Provides Sustained Protection Against Anaphylaxis

The unique immune communication between skin and gastrointestinal tract can be used to generate long-lasting protection from food allergies.

Viaskin Peanut, Milk and Egg Patch Therapies: Promising News from the...

We are cautiously optimistic that a safe, effective, easy to administer treatment for food allergy may be on the horizon.

Viaskin Milk Patch Receives Positive Recommendation to Proceed to Phase II

The board overseeing the Phase I study of the milk allergy therapy found no safety concerns.

Peanut Patch Receives FDA’s Breakthrough Therapy Designation

The Viaskin Peanut patch received the BT designation after a positive Phase IIb trial.

Connect with Us

38,129FansLike
578FollowersFollow
2,656FollowersFollow
5,437FollowersFollow
38SubscribersSubscribe